Gaudenz joined Cellestia as the Chief Financial Officer in 2017. He has more than 20 years of experience in the field of strategic, operational and financial management for several public and private companies. Before joining Cellestia, Gaudenz was the CFO of PIQUR Therapeutics AG where he had a leading role in raising over 300 million in equity and debt. Prior to that he was the CFO at Helvetica Property Investors AG, an asset management advisor. In his earlier career, he held finance positions at Carbogen Amcis AG, UBS, and BroadVision in the UK.
“My relationship with Cellestia started as a Seed investor. As my understanding of what this team was trying to achieve grew, I knew I wanted to be a part of the journey.”
He obtained his degree in Economics and Management from the University of Applied Sciences in Basel.